Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 105

1.

Prognostic significance of MET amplification and expression in gastric cancer: a systematic review with meta-analysis.

Peng Z, Zhu Y, Wang Q, Gao J, Li Y, Li Y, Ge S, Shen L.

PLoS One. 2014 Jan 8;9(1):e84502. doi: 10.1371/journal.pone.0084502. eCollection 2014. Review.

PMID:
24416238
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

C-Met as a prognostic marker in gastric cancer: a systematic review and meta-analysis.

Yu S, Yu Y, Zhao N, Cui J, Li W, Liu T.

PLoS One. 2013 Nov 4;8(11):e79137. doi: 10.1371/journal.pone.0079137. eCollection 2013. Review.

PMID:
24223894
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

The prognostic significance of amplification and overexpression of c-met and c-erb B-2 in human gastric carcinomas.

Nakajima M, Sawada H, Yamada Y, Watanabe A, Tatsumi M, Yamashita J, Matsuda M, Sakaguchi T, Hirao T, Nakano H.

Cancer. 1999 May 1;85(9):1894-902.

PMID:
10223227
[PubMed - indexed for MEDLINE]
4.

MET amplification is not rare and predicts unfavorable clinical outcomes in patients with recurrent/metastatic gastric cancer after chemotherapy.

An X, Wang F, Shao Q, Wang FH, Wang ZQ, Wang ZQ, Chen C, Li C, Luo HY, Zhang DS, Xu RH, Li YH.

Cancer. 2014 Mar 1;120(5):675-82. Epub 2013 Nov 5.

PMID:
24804300
[PubMed - indexed for MEDLINE]
5.

MET expression and amplification in patients with localized gastric cancer.

Janjigian YY, Tang LH, Coit DG, Kelsen DP, Francone TD, Weiser MR, Jhanwar SC, Shah MA.

Cancer Epidemiol Biomarkers Prev. 2011 May;20(5):1021-7. doi: 10.1158/1055-9965.EPI-10-1080. Epub 2011 Mar 10.

PMID:
21393565
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Prognostic value of survivin in patients with gastric cancer: a systematic review with meta-analysis.

Liu JL, Gao W, Kang QM, Zhang XJ, Yang SG.

PLoS One. 2013 Aug 2;8(8):e71930. doi: 10.1371/journal.pone.0071930. Print 2013. Review.

PMID:
23936532
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Impact of MET amplification on gastric cancer: possible roles as a novel prognostic marker and a potential therapeutic target.

Lee J, Seo JW, Jun HJ, Ki CS, Park SH, Park YS, Lim HY, Choi MG, Bae JM, Sohn TS, Noh JH, Kim S, Jang HL, Kim JY, Kim KM, Kang WK, Park JO.

Oncol Rep. 2011 Jun;25(6):1517-24. doi: 10.3892/or.2011.1219. Epub 2011 Mar 18.

PMID:
21424128
[PubMed - indexed for MEDLINE]
8.

Prognostic value of epidermal growth factor receptor in patients with gastric cancer: a meta-analysis.

Hong L, Han Y, Yang J, Zhang H, Jin Y, Brain L, Li M, Zhao Q.

Gene. 2013 Oct 15;529(1):69-72. doi: 10.1016/j.gene.2013.07.106. Epub 2013 Aug 13.

PMID:
23954221
[PubMed - indexed for MEDLINE]
9.

Antitumor action of the MET tyrosine kinase inhibitor crizotinib (PF-02341066) in gastric cancer positive for MET amplification.

Okamoto W, Okamoto I, Arao T, Kuwata K, Hatashita E, Yamaguchi H, Sakai K, Yanagihara K, Nishio K, Nakagawa K.

Mol Cancer Ther. 2012 Jul;11(7):1557-64. doi: 10.1158/1535-7163.MCT-11-0934. Epub 2012 Jun 22.

PMID:
22729845
[PubMed - indexed for MEDLINE]
Free Article
10.

Prognostic significance of vascular endothelial growth factor immunohistochemical expression in gastric cancer: a meta-analysis.

Peng L, Zhan P, Zhou Y, Fang W, Zhao P, Zheng Y, Xu N.

Mol Biol Rep. 2012 Oct;39(10):9473-84. doi: 10.1007/s11033-012-1812-8. Epub 2012 Jun 23.

PMID:
22729879
[PubMed - indexed for MEDLINE]
11.

MET in gastric carcinomas: comparison between protein expression and gene copy number and impact on clinical outcome.

Lee HE, Kim MA, Lee HS, Jung EJ, Yang HK, Lee BL, Bang YJ, Kim WH.

Br J Cancer. 2012 Jul 10;107(2):325-33. doi: 10.1038/bjc.2012.237. Epub 2012 May 29.

PMID:
22644302
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Amplification of the c-met, c-erbB-2 and epidermal growth factor receptor gene in human gastric cancers: correlation to clinical features.

Tsugawa K, Yonemura Y, Hirono Y, Fushida S, Kaji M, Miwa K, Miyazaki I, Yamamoto H.

Oncology. 1998 Sep-Oct;55(5):475-81.

PMID:
9732228
[PubMed - indexed for MEDLINE]
13.

Genetic activation of the MET pathway and prognosis of patients with high-risk, radically resected gastric cancer.

Graziano F, Galluccio N, Lorenzini P, Ruzzo A, Canestrari E, D'Emidio S, Catalano V, Sisti V, Ligorio C, Andreoni F, Rulli E, Di Oto E, Fiorentini G, Zingaretti C, De Nictolis M, Cappuzzo F, Magnani M.

J Clin Oncol. 2011 Dec 20;29(36):4789-95. doi: 10.1200/JCO.2011.36.7706. Epub 2011 Oct 31.

PMID:
22042954
[PubMed - indexed for MEDLINE]
Free Article
14.

TNK2 gene amplification is a novel predictor of a poor prognosis in patients with gastric cancer.

Shinmura K, Kiyose S, Nagura K, Igarashi H, Inoue Y, Nakamura S, Maeda M, Baba M, Konno H, Sugimura H.

J Surg Oncol. 2014 Mar;109(3):189-97. doi: 10.1002/jso.23482. Epub 2013 Oct 31.

PMID:
24178904
[PubMed - indexed for MEDLINE]
15.

The prognostic significance of amplification and overexpression of c-met and c-erb B-2 in human gastric carcinomas.

Carneiro F, Sobrinho-Simoes M.

Cancer. 2000 Jan 1;88(1):238-40. No abstract available.

PMID:
10618628
[PubMed - indexed for MEDLINE]
16.

Overexpression of the c-met protooncogene in human gastric carcinoma--correlation to clinical features.

Huang TJ, Wang JY, Lin SR, Lian ST, Hsieh JS.

Acta Oncol. 2001;40(5):638-43.

PMID:
11669338
[PubMed - indexed for MEDLINE]
17.

MET overexpression assessed by new interpretation method predicts gene amplification and poor survival in advanced gastric carcinomas.

Ha SY, Lee J, Kang SY, Do IG, Ahn S, Park JO, Kang WK, Choi MG, Sohn TS, Bae JM, Kim S, Kim M, Kim S, Park CK, Ignatius Ou SH, Kim KM.

Mod Pathol. 2013 Dec;26(12):1632-41. doi: 10.1038/modpathol.2013.108. Epub 2013 Jun 28.

PMID:
23807774
[PubMed - indexed for MEDLINE]
Free Article
18.

Gastric cancer cell line Hs746T harbors a splice site mutation of c-Met causing juxtamembrane domain deletion.

Asaoka Y, Tada M, Ikenoue T, Seto M, Imai M, Miyabayashi K, Yamamoto K, Yamamoto S, Kudo Y, Mohri D, Isomura Y, Ijichi H, Tateishi K, Kanai F, Ogawa S, Omata M, Koike K.

Biochem Biophys Res Commun. 2010 Apr 16;394(4):1042-6. doi: 10.1016/j.bbrc.2010.03.120. Epub 2010 Mar 21.

PMID:
20331976
[PubMed - indexed for MEDLINE]
19.

Poor prognosis of phosphatase of regenerating liver 3 expression in gastric cancer: a meta-analysis.

Hu L, Luo H, Wang W, Li H, He T.

PLoS One. 2013 Oct 18;8(10):e76927. doi: 10.1371/journal.pone.0076927. eCollection 2013.

PMID:
24204707
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Frequent amplification of the c-met gene in scirrhous type stomach cancer.

Kuniyasu H, Yasui W, Kitadai Y, Yokozaki H, Ito H, Tahara E.

Biochem Biophys Res Commun. 1992 Nov 30;189(1):227-32.

PMID:
1333188
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk